000 00390nam a2200133Ia 4500
008 170516s9999 xx 000 0 und d
245 _aAnalytical Challenges and Regulatory Requirements for Nasal Drug Products in Europe and the U.S.
260 _bPharmaceutics
260 _c2014
300 _a6:2
500 _aJune
650 _xPharmacy
856 _uhttp://www.mdpi.com/1999-4923/6/2
999 _c330992
_d330992